skip to the content

Clinical Trials

Brain Networks in Parkinson's Disease

Protocol ID

04-113T

Protocol Description

Dopamine is a chemical in the brain (called a neurotransmitter) that is involved in movement.  In Parkinson’s disease, levels of this neurotransmitter are decreased in certain regions of the brain.  The purpose of this study is to measure different types of brain function in patients with Parkinson’s disease and in normal volunteers. This will be done by taking brain scans that measure blood flow in the brain (cerebral blood flow), that measure how your brain uses energy (glucose metabolism), and that measure neurotransmitter (dopamine) levels.

Eligibility Criteria

Patients with Parkinson's disease and healthy controls

Primary Investigator(s)

  • Michael Pourfar, MD

Contact Information

Toni Flanagan
(516) 562-2685
tflanagan@nshs.edu

Last Update

April 9, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Neurosciences:
top
top